Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Prospective, Multi-Center, Randomized, Blinded Study to Evaluate Durasphere FI for the Treatment of Fecal Incontinence

Study:

Phase 2 IDE Study of Durasphere FI in the Treatment of Fecal Incontinence

Rationale:

n/a

Purpose:

The purpose of this study is to evaluate a new injectable bulking agent for the treatment of fecal incontinence in adult men and women. This study has been designed to assess the safety, effectiveness and performance of Durasphere in adults suffering from fecal incontinence under monitored clinical conditions. The frequency and severity of fecal incontinence symptoms will be measured using a modified Cleveland Clinic Incontinence Score as the primary criteria by which success is evaluated.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Fecal Incontinence Device: Durasphere FI
Device: Sham
Phase 2

Verified by Carbon Medical Technologies September, 2008

Sponsored by: Carbon Medical Technologies
Information provided by: Carbon Medical Technologies
ClinicalTrials.gov identifier: NCT00762047

Study Type: Interventional

Study Design: Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study

Cleveland Clinic Florida-Weston
Weston, Florida 33331
United States

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site